Simpler Grants.gov #RFA-TR-26-001

NIH Solicits Development of Electronic Nose Technology for Disease Diagnosis (SCENT III)

The National Institutes of Health (NIH), through the National Center for Advancing Translational Sciences (NCATS), is seeking proposals for the development of advanced electronic nose technologies for noninvasive disease diagnosis. - Government Buyer: - National Institutes of Health (NIH) - National Center for Advancing Translational Sciences (NCATS) - Products/Services Requested: - Research and development of electronic nose platforms that mimic the human olfactory system - Technologies must detect volatile organic compound (VOC) signatures from human skin as disease biomarkers - Emphasis on improved sensing, detection, and analytical tools for integration into diagnostic and monitoring platforms - Unique or Notable Requirements: - Use of systems engineering and artificial intelligence in technology development - Platform must be validated and meet regulatory approval standards - Clinical trials are not permitted under this opportunity - OEMs and Vendors: - No specific OEMs or vendors are named; this is an open research and development solicitation - Additional Details: - Solicitation number: RFA-TR-26-001 - Funding instrument: Cooperative agreement

Description

This Notice of Funding Opportunity (NOFO) seeks to develop electronic nose technologies that mimic the olfactory system to create a robust diagnostic platform subject to validation and regulatory approval. The technology aims to detect volatile organic compound (VOC) signatures from human skin, which serve as biomarkers for various diseases. The goal is to improve sensing, detection, and analytical technologies for disease diagnosis and monitoring in everyday settings, complementing traditional invasive procedures. The platform is noninvasive and provides real-time, in situ diagnosis to accelerate treatment development for various disease conditions.

View original listing